1-4 of 4
Shinichiro Nishimura, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Continuous Cytarabine Plus Dexamethasone in Consolidation Phase to Patients with Childhood ALL: Result from Japan Association of Childhood Leukemia Study - JACLS ALL02 Protocol -

So-ichi Suenobu, MD PhD, Ikuya Usami, MD PhD, Toshihiko Imamura, MD PhD, Hirohide Kawasaki, MD PhD, Keiko Yumura Yagi, MD PhD, Shinichiro Nishimura, MD PhD, Makoto Kaneda, MD PhD, Yoshihiro Takahashi, MD PhD, Daiichiro Hasegawa, MD PhD, Nobuhiro Suzuki, MD PhD, Yoshiko Hashii, MD PhD, Takao Deguchi, MD PhD, Saito Akiko, MD PhD, Koji Kato, MD PhD, Yoshiyuki Kosaka, MD PhD, Mikiya Endo, MD PhD, Akihiro Iguchi, MD PhD, Megumi Oda, MD PhD, Hiroki Hori, MD PhD, Atsushi Sato, MD PhD, Tatsutoshi Nakahata, MD PhD, Tooru Kudoh, MD PhD, Junichi Hara, MD PhD, Keizo Horibe, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2802.
https://doi.org/10.1182/blood.V128.22.2802.2802
Published: 2016
Journal Articles

The Outcome of Low-Risk Childhood B-Cell Precursor ALL Treated with the Japan Association of Childhood Leukemia Study (JACLS) ALL-02 Trial

Yoshihiro Takahashi, MD PhD, Toshihiko Imamura, MD PhD, Ikuya Usami, MD PhD, Keiko Yumura-Yagi, Soichi Suenobu, Daiichiro Hasegawa, MD PhD, Shinichiro Nishimura, MD PhD, Nobuhiro Suzuki, MDPhD, Yoshiko Hashii, MD PhD, Takao Deguchi, MD PhD, Akiko M. Saito, MD PhD, Yoshihiro Komada, MD PhD, Yoshiyuki Kosaka, MD PhD, Koji Kato, MD PhD, Ryoji Kobayashi, MD PhD, Hirohide Kawasaki, MD PhD, Hiroki Hori, MD PhD, Atsushi Sato, MD PhD, Tooru Kudo, MD PhD, Tatsutoshi Nakahata, MD PhD, Megumi Oda, MD PhD, Junichi Hara, MD PhD, Keizo Horibe, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1604.
https://doi.org/10.1182/blood.V128.22.1604.1604
Published: 2016
Journal Articles

Successful Abolition of Prophylactic Cranial Irradiation in Children with Non-T Acute Lymphoblastic Leukemia (ALL) in the Japan Association of Childhood Leukemia Study (JACLS) ALL-02 Trial

Daiichiro Hasegawa, MD, PhD, Junichi Hara, MD, PhD, Souichi Suenobu, MD, PhD, Yoshihiro Takahashi, MD, PhD, Atsushi Sato, MD, PhD, Nobuhiro Suzuki, MD, PhD, Shinichiro Nishimura, MD, PhD, Keiko Yumura-Yagi, MD, PhD, Hirohide Kawasaki, MD, PhD, Hiroki Hori, MD, PhD, Akiko M. Saito, MD, PhD, Koji Kato, MD, PhD, Akihiro Iguchi, MD, PhD, Tooru Kudo, MD, PhD, Tatsutoshi Nakahata, MD, PhD, Megumi Oda, MD, PhD, Keizo Horibe, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1506.
https://doi.org/10.1182/blood.V118.21.1506.1506
Published: 2011
Journal Articles

Effective Risk-Adapted Therapy for Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL) with the Japan Association of Childhood Leukemia Study (JACLS) ALL-97 Protocol.

Keizo Horibe, MD, Tooru Kudoh, MD, Hiroki Hori, MD, Shinichiro Nishimura, MD, Megumi Oda, MD, Makoto Yoshida, MD, Yoshihiro Komada, MD, Junichi Hara, MD, Akio Tawa, MD, Ikuya Usami, MD, Akihiko Tanizawa, MD, Keiko Yumura-Yagi, MD
Journal: Blood
Blood (2006) 108 (11): 1874.
https://doi.org/10.1182/blood.V108.11.1874.1874
Published: 2006